Spinal and peripheral analgesic effects of the CB cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain. (full - 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2931557/?toolubmed
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss. (full - 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2871326/
The endocannabinoid system and cancer: therapeutic implication (full – 2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01327.x/full
Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model (abst – 2011) http/www.unboundmedicine.com/medline/ebm/record/21195743/abstract/Antinociceptive_effect_of_intrathecal_cannabinoid_ receptor_agonist_WIN_55212_2_in_a_rat_bone_tumor_p ain_model_
Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice (abst - 2011) http/www.unboundmedicine.com/medline/ebm/record/21771590/abstract/Antinociceptive_effects_induced_through_the_stimul ation_of_spinal_cannabinoid_type_2_receptors_in_ch ronically_inflamed_mice_
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3339795/?toolubmed
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists. (full – 2012) http/onlinelibrary.wiley.com/doi/10.1002/jbmr.1732/full
Role of cannabinoid 2 receptor in the development of bone cancer pain (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22490961
Suppression of vascular endothelial growth factor expression by cannabinoids in a canine osteosarcoma cell line (link to PDF – 2013) http/www.dovepress.com/suppression-of-vascular-endothelial-growth-factor-expression-by-cannaba13597
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23518609
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of Cfiber nociceptors in a murine model of cancer pain. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23673278
Inflammatory signaling as a therapeutic target for the treatment of breast cancer-induced bone pain. (abst – 2013) http/www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/887.10?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Pharmacology of Cannabinoid Receptor Agonists and a Cyclooxygenase-2 Inhibitor in Rat Bone Tumor Pain. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24008428
Involvement of PAR-4 in Cannabinoid-Dependent Sensitization of Osteosarcoma Cells to TRAIL-Induced Apoptosis. (full – 2014) http/www.ijbs.com/v10p0466.htm
Cannabinoids as therapeutic agents in cancer: current status and future implications. (link to PDF- 2014) http/www.impactjournals.com/oncotarget/index.php?journalncotarget&page=article&op=view&path[]=2233
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss. (full - 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2871326/
The endocannabinoid system and cancer: therapeutic implication (full – 2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01327.x/full
Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model (abst – 2011) http/www.unboundmedicine.com/medline/ebm/record/21195743/abstract/Antinociceptive_effect_of_intrathecal_cannabinoid_ receptor_agonist_WIN_55212_2_in_a_rat_bone_tumor_p ain_model_
Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice (abst - 2011) http/www.unboundmedicine.com/medline/ebm/record/21771590/abstract/Antinociceptive_effects_induced_through_the_stimul ation_of_spinal_cannabinoid_type_2_receptors_in_ch ronically_inflamed_mice_
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3339795/?toolubmed
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists. (full – 2012) http/onlinelibrary.wiley.com/doi/10.1002/jbmr.1732/full
Role of cannabinoid 2 receptor in the development of bone cancer pain (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22490961
Suppression of vascular endothelial growth factor expression by cannabinoids in a canine osteosarcoma cell line (link to PDF – 2013) http/www.dovepress.com/suppression-of-vascular-endothelial-growth-factor-expression-by-cannaba13597
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23518609
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of Cfiber nociceptors in a murine model of cancer pain. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23673278
Inflammatory signaling as a therapeutic target for the treatment of breast cancer-induced bone pain. (abst – 2013) http/www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/887.10?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Pharmacology of Cannabinoid Receptor Agonists and a Cyclooxygenase-2 Inhibitor in Rat Bone Tumor Pain. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24008428
Involvement of PAR-4 in Cannabinoid-Dependent Sensitization of Osteosarcoma Cells to TRAIL-Induced Apoptosis. (full – 2014) http/www.ijbs.com/v10p0466.htm
Cannabinoids as therapeutic agents in cancer: current status and future implications. (link to PDF- 2014) http/www.impactjournals.com/oncotarget/index.php?journalncotarget&page=article&op=view&path[]=2233